股票/基金 实时行情 股吧

简称:太龙药业 代码:600222


会计年度:2021-12-31收入分布
项目名称主营业务收入主营业务成本主营业务毛利毛利率
合计1,604,516,940.001,141,450,230.76463,066,709.2428.86
其他(补充)2,830,336.831,179,791.761,650,545.0758.32
药品研发服务324,126,938.07170,619,720.33153,507,217.7447.36
药品药材流通102,895,135.7299,469,719.463,425,416.263.33
药品制造1,174,664,529.38870,180,999.21304,483,530.1725.92

会计年度:2021-06-30 
项目名称主营业务收入主营业务成本主营业务毛利毛利率
分部间抵销-27,080,830.75-26,657,657.66-423,173.091.56
合计751,871,898.69539,678,535.61212,193,363.0828.22
其他1,234,798.93306,994.07927,804.8675.14
药品研发服务135,684,497.2274,408,594.5461,275,902.6845.16
药品药材流通67,616,350.6563,347,209.694,269,140.966.31
药品制造574,417,082.64428,273,394.97146,143,687.6725.44

会计年度:2020-12-31 
项目名称主营业务收入主营业务成本主营业务毛利毛利率
合计1,417,097,311.591,042,224,907.13374,872,404.4626.45
其他(补充)1,399,642.07138,988.381,260,653.6990.07
药品研发服务238,790,715.73119,455,630.77119,335,084.9649.97
药品药材流通88,618,611.1782,158,128.586,460,482.597.29
药品制造1,088,288,342.62840,472,159.40247,816,183.2222.77

会计年度:2020-06-30 
项目名称主营业务收入主营业务成本主营业务毛利毛利率
分部间抵销-27,290,463.80-27,290,463.80----
合计647,757,181.42411,294,338.19236,462,843.2336.50
其他(补充)129,827.9820,752.84109,075.1484.02
药品研发服务81,931,821.0442,887,315.3439,044,505.7047.65
药品药材流通35,994,875.4632,496,521.003,498,354.469.72
药品制造556,991,120.74363,180,212.82193,810,907.9234.80

会计年度:2019-12-31 
项目名称主营业务收入主营业务成本主营业务毛利毛利率
合计1,311,814,818.00827,452,511.00484,362,307.0036.92
其他(补充)622,543.38945,719.44-323,176.06-51.91
药品研发服务224,318,388.60115,435,098.78108,883,289.8248.54
药品药材流通91,400,625.0084,149,617.157,251,007.857.93
药品制造995,473,261.02626,922,075.64368,551,185.3837.02

    1/9 转到